I N F O R M A T I O N

   In 1999, Cornell University and the Ludwig Institute for Cancer Research entered into a unique partnership to manage a number of anticipated collaborative activities. The first of which, the Bioprocess Research Laboratory, is already operational.. The partnership defines not just the working relationship between Cornell University and the Ludwig Institute of Cancer Research but illustrates a unique alliance between two institutions.

   The Ludwig Institute for Cancer Research is a global cancer research enterprise staffed by more than 800 scientists, clinicians, and support personnel. It bears the name of its founder Daniel Ludwig. Research operations are on-going at ten Institute Branches located in seven different countries around the world and are augmented by a vital network of collaborations with laboratory and clinical investigators at a host of academic institutions. The administrative headquarters of the Institute are in New York City and the Institute maintains a research Branch at Memorial Sloan Kettering in New York City as well.

   The Cornell University/Ludwig Institute for Cancer Research Partnership is a vital link in the process from the discovery of tumor antigens in the laboratory to the assessing of their therapeutic potential in the clinic. The Partnership represents a dynamic coalition of two world-class institutions dedicated to a unique enterprise whose goal is "finding ways to relieve the human suffering caused by cancer".